Cellyan Biotechnology shares are trading higher after the company announced it was granted a 180-day Nasdaq extension to regain compliance.
benzinga_article Cellyan Biotechnology shares are trading higher after the company announced it was granted a 180-day Nasdaq extension to regain compliance.
